Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications

Journal of Clinical Psychopharmacology

Volumn 27, Issue 6, 2007, Pages 707-710

  Wang, Philip S ^a,b   Schneeweiss, Sebastian ^b   Setoguchi, Soko ^b   Patrick, Amanda ^b   Avorn, Jerry ^b   Mogun, Helen ^b   Choudhry, Niteesh K ^b   Brookhart, M Alan ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE; BENZODIAZEPINE DERIVATIVE; DIBENZOTHIAZEPINE DERIVATIVE; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE; THIAZOLE DERIVATIVE;

ACUTE HEART INFARCTION; AGED; AGING; BACTERIAL INFECTION; BEHAVIOR DISORDER; CEREBROVASCULAR DISEASE; CONGESTIVE HEART FAILURE; DEMOGRAPHY; DOSE RESPONSE; DRUG EFFICACY; FOOD AND DRUG ADMINISTRATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; LETTER; MORTALITY; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; CHEMICALLY INDUCED DISORDER; DEMENTIA; DRUG USE; ELDERLY CARE; FACTUAL DATABASE; HEART ARRHYTHMIA; METHODOLOGY; ORAL DRUG ADMINISTRATION; PHARMACY; RISK ASSESSMENT; STATISTICS; STROKE;

ADMINISTRATION, ORAL; AGED; ANTIPSYCHOTIC AGENTS; ARRHYTHMIAS, CARDIAC; BENZODIAZEPINES; CLOZAPINE; DATABASES, FACTUAL; DEMENTIA; DIBENZOTHIAZEPINES; DRUG UTILIZATION REVIEW; HEALTH SERVICES FOR THE AGED; HUMANS; PHARMACEUTICAL SERVICES; PIPERAZINES; QUINOLONES; RISK ASSESSMENT; RISPERIDONE; STROKE; THIAZOLES; TREATMENT OUTCOME;

EID: 39649084693     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31815a882b     Document Type: Letter

References (18)

1. US Food and Drug Administration. FDA public health advisory: deaths with antipsychotics in elderly patients with behavioral disturbances. Available at: www.fda.gov/cder/drug/advisory/antipsychotics.htm. Accessed April 15, 2005.
2. Dewa CS, Remington G, Herrmann N, et al. How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experience. Clin Ther. 2002;24:1466-1476.
3. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. NEJM. 2005;353:2335-2341.
4. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005; 294:1934-1943.
5. Nasrallah HA, White T, Nasrallah AT. Lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol. Am J Geriatr Psychiatry. 2004;12: 437-439.
6. Alexopoulos GS, Streim J, Carpenter D, et al. Using antipsychotic agents in older patients: Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients. J Clin Psychiatry. 2004;65(suppl 2):5-99.
7. Brookhart MA, Wang PS, Solomon DH, et al. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology. 2006;17:268-275.
8. Kelly HG, Fay JE, Lavery SG. Thioridazine hydrochloride (Mellaril): its effects on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities. Can Med Assoc J. 1963;89:546-554.
9. Hennessy S, Bilker WB, Knauss JS, et al. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. Br Med J. 2002;325: 1070-1074.
10. Straus SMJM, Bleumink GS, Dieleman JP, et al. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med. 2004;164: 1293-1297.
11. Reilly JG, Ayis SA, Ferrier IN, et al. Thioridazine and sudden unexplained death in psychiatric inpatients. Br J Psychiatry. 2002;180: 515-522.
12. Ray WA, Meredith S, Thapa PB, et al. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry. 2001;58:1161-1167.
13. Glassman AH, Bigger JT. Antipsychotic drugs: prolonged QTc Interval, torsade de pointes, and sudden death. Am J Psychiatry. 2001;158:1774-1782.
14. Liperoti R, Gambassi G, Lapane KL, et al. Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest. Arch Intern Med. 2005;165:696-701.
15. Miklossy J. Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease. Neurol Res. 2003;25: 605-610.
16. Herrmann N, Mamdani MDP, Lanctot KL. Atypical antipsychotics and the risk of cerebrovascular accidents. Am J Psychiatry. 2004; 161:1113-1115.
17. Liperoti R, Gambassi G, Lapane KL, et al. Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics. J Clin Psychiatry. 2005;66:1090-1096.
18. Rabins PV, Lyketsos CG. Antipsychotic drugs in dementia: what should be made of the risks? JAMA. 2005;294:1963-1965.